FDA Approved: CARVEDILOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for carvedilol submitted by Teva Pharmaceuticals USA, Inc., authorizing a generic carvedilol product under ANDA 076373.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Left Ventricular Dysfunction Following Myocardial Infarction

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

SUPPL AP for CARVEDILOL (CARVEDILOL)